key: cord-0259713-6o28ja8r authors: Ko, Y.; Mendoza, V. M. P.; Seo, Y.; Lee, J.; Kim, Y.; Kwon, D.; Jung, E. title: Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant date: 2021-11-01 journal: nan DOI: 10.1101/2021.11.01.21265729 sha: 4b06aba3ca645b098670148124a69dc8d8beb006 doc_id: 259713 cord_uid: 6o28ja8r Background: Early vaccination efforts and non-pharmaceutical interventions were insufficient to prevent a surge of coronavirus disease 2019 (COVID-19) cases triggered by the Delta variant. This study aims to understand how vaccination and variants contribute to the spread of COVID-19 so that appropriate measures are implemented. Methods: A compartment model that includes age, vaccination, and infection with the Delta or non-Delta variants was developed. We estimated the transmission rates using maximum likelihood estimation and phase-dependent reduction effect of non-pharmaceutical interventions (NPIs) according to government policies from 26 February to 8 October 2021. We extended our model simulation until 31 December considering the initiation of eased NPIs. Furthermore, we also performed simulations to examine the effect of NPIs, arrival timing of Delta variant, and speed of vaccine administration. Results: The estimated transmission rate matrices show distinct pattern, with the transmission rates of younger age groups (0~39 years) much larger than non-Delta. Social distancing (SD) level 2 and SD4 in Korea were associated with transmission reduction factors of 0.64 to 0.69 and 0.70 to 0.78, respectively. The easing of NPIs to a level comparable to SD2 should be initiated not earlier than 16 October to keep the number of severe cases below the capacity of Korean healthcare system. Simulation results also showed that a surge prompted by the spread of the Delta variant can be prevented if the number of people vaccinated daily was larger. Conclusions: Simulations showed that the timing of easing and intensity of NPIs, vaccination speed, and screening measures are key factors in preventing another epidemic wave. : The model flowchart describing the transmission of COVID-19 with the non-Delta or Delta variants. The susceptible class of age group i, denoted by S i , can be exposed to the non-Delta or Delta variants (E nonδ i , E δ i ) with forces of infection λ nonδ i or λ δ i , respectively. The transmission reduction factor µ(t) quantifies the NPIs according to government policy. Also, S i can become effectively V i or ineffectively U i vaccinated, depending on the daily number of vaccinated individuals ν i , and vaccine effectiveness to the non-Delta variant e part i . Individuals in V i become partially P part i or fully protected P f ull i from infection after 1/ω i days on average, or may be exposed to the non-Delta or Delta variant (E nonδ i,v , E δ i,v ). Vaccine effectiveness to the Delta variant is denoted by e f ull i . The mean latent period of the non-Delta and Delta variants are 1/κ nonδ and 1/κ δ days, respectively. The mean infectious period is 1/α days. Those in the infectious classes (I nonδ i , I δ i , I nonδ i,v and I nonδ i,v ) are isolated as soon as confirmed, and are classified as mild (Q m i , Q m i,v ) or severe (Q s i , Q s i,v ). Individuals in the isolated compartments may die or recover (R i ) after 1/γ days on average. The parameters p i , p i,v represent the proportion that becomes severe and f i , f i,v are the mean fatality rates of the unvaccinated and vaccinated individuals, respectively. [10], effectiveness of these vaccines to the Delta and non-Delta variants [3] , 122 and interval between doses [11] . The transmission rates β for the Delta and CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. development are found in Appendix A. We apply MLE to estimate the transmission rates of the Delta and non-Delta scenario 1 (S1), µ = 0.64 in scenario 2 (S2), and µ = 0.52 in scenario 3 (S3). The 142 estimated value obtained from 16 April to 3 June 2021 is S1, and the minimum 143 value estimated in this study is S2 (from 16 June to 11 July 2021). The value of 144 µ in S3 was estimated from the third epidemic wave in 2020, when it was SD1, 145 and is a relatively lower value compared to S2 [13] . 146 We also proceeded with simulation-based experiment to study the effects 147 of varying the speed of vaccination, arrival timing of the Delta variant, and in-148 tensity of NPIs. In this case, the initial condition of simulations is identical to 149 26 February 2021 in Korea and the simulation time is set to 365 days. The total 150 number of vaccinated people is assumed to be 40 million, which is approxi-151 mately 78% of the population in Korea, and the number of people vaccinated 152 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 daily is set to 150 000, 200 000, or 400 000. Moreover, we fix the order of vac-153 cination from oldest to youngest, that is, 8-7-6-5-4-3-2, excluding group 1. We 154 denote by t δ the day when the individuals exposed to the Delta variant arrived 155 in the local community, and we set its range from zero to 80 days. Note that 156 in Korea, the date of arrival of the Delta variant corresponds to t δ = 52. We Since the various government policies including SD implemented during 166 the periods considered in estimating the transmission rates, we normalize the 167 transmission rate matrices to exclude phase-dependent factors. The details of 168 the computation are found in Appendix C. 169 We use the normalized transmission rate matrices in estimating the factor 170 µ(t), which represents the reduction in transmission induced by NPIs accord-171 ing to government policy. Table 1 presents the estimates for each phase from CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 ber (R t , blue curve) described in Appendix C. At the start of the simulation period, Seoul Capital Area was at SD2. When µ(t) increased from 0.64 to 0.69 To illustrate how µ can be used to suggest appropriate SD level, assume 189 11 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; that the basic reproductive number of the disease is five, Delta and non-Delta variants can infect the population, 80% of population is vaccinated, and vac-191 cine effectiveness is 62.5%. Then without NPIs, R t = 5 × 0.8 × 0.625 = 2.5. To 192 maintain an R t below one, SD2 is appropriate since the minimum estimated 193 value of µ(t) on SD2 was 0.64 and this translates to R t = (1 − 0.64) × 2.5 = 0.9. On the other hand if µ = 0.52, which represents worst case during SD1, then CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; Figure 3 : The parameter estimation results obtained by fitting the model to the cumulative confirmed cases. Panel (a) shows the effective reproductive number (blue), estimates of the transmission reduction factor µ(t) (red), proportion of the active cases infected with the Delta variant (black solid curve), and proportion of the total population who has immunity (black dashed curve). Panel (b) shows the best fit of the model to the daily confirmed cases and (c) the best fit of the model to the cumulative confirmed cases. The boxes represent the data for the daily and cumulative cases from 26 February to 8 October 2021. patients, and cumulative deaths could reach 8207, 1617, and 6528, respectively. But if the easing to S3 was started later, on 18 October or 1 November, the peak 217 numbers could be reduced to 4385 (40.48% reduction) or 1961 (76.11% reduc-218 tion) for the peak daily cases, 879 (45.64% reduction) or no increase for the peak 219 13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101/2021.11.01.21265729 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101/2021.11.01.21265729 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101/2021.11.01.21265729 doi: medRxiv preprint Figure 6 : The simulation result with µ = 0.67, t δ = 52, and daily number of vaccination set to 200 000 or 400 000. Panel (a) shows the effective reproductive number, (b) number of daily confirmed cases, (c) number of severe patients requiring hospital beds, (d) cumulative number of deaths, (e) age-dependent number of confirmed cases, and (f) age-dependent number of deaths. Red and blue colours indicate that the number of daily administered vaccines is 200 000 and 400 000, respectively. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101/2021.11.01.21265729 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 The transmission rate matrix in this study was apparently different between 250 the Delta and non-Delta variants and by age groups. The transmission rate 251 with non-Delta variant was high between the same age groups. However, 252 transmission with the Delta variant was much higher among age groups of CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. In our generalized simulation on the effects of vaccination and NPIs, the 292 larger reduction of transmission factor (µ(t)) and faster vaccination rollout 293 or earlier implementation of stricter NPIs (e.g., expanding genomic testing to 294 people entering from high-risk countries or elevating SD) resulted in less inci-295 dence, severe cases, and deaths. We are aware that the supply of vaccines is not CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 ces. For example, transmission rate among those age 0-17 might be underes-303 timated because of restricted attendance in schools. Second, vaccine waning 304 is not considered. However, booster shots are administered and vaccine hes-305 itancy remains low in Korea, which mean that the effect of administered vac-306 cines might be maintained [22] . Third, our age-age matrix focused on the Delta 307 variant, and we were not able to examine transmission of other previous vari- CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; This study illustrated the higher transmissibility of the Delta relative to the CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; grant funded by the Korean government (MEST) (NRF-2021R1A2C100448711). The following system of ordinary differential equations describes the de- . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 veloped age-structured model: where the forces of infection λ nonδ i and λ δ i are defined as is the phase-dependent, transmission reduction factor accounting for NPIs and its estimated values are in Table 1 , β nonδ ij and β δ ij are the transmission rates 24 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 between age groups, and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 To establish the likelihood function to be optimized, we first divide each age group into three subgroups to distinguish COVID-19 outcomes: infected (Λ Ii ), unvaccinated and uninfected (Λ Si ), and effectively vaccinated and uninfected (Λ Vi ), where i indicates the age group. Let β XY be the transmission rate from age group Y to X. Assuming a homogeneous mixing of the population, and that the transmission events are exponentially distributed, the probability that an individual x in subgroup Λ at the time t − 1 is still uninfected until the next time t is given by where I j (t − 1) denotes the number of hosts in group j which can spread the 375 disease at time t − 1, and N is the total population. We can set N as a constant 376 because the number of isolated individuals (or deceased) is less than 0.02% 377 of the population. On the other hand, the probability that an individual x in 378 27 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 group Λ is uninfected at the time t − 1 but becomes infected at t is Hence, an individual who stays uninfected until final time t f has probabilities 380 p S,Λ,x (t) at each time until t f . In addition, an individual can be vaccinated at 381 time t Vi,x , have immunity after t e,i days, and stay uninfected until final time t f . An individual infected at time t Ii,x has probabilities p S,Λ,x (t) until t Ii,x − 1 and 383 p Ii,Λ,x (t Ii,x ). The likelihood function L is formulated as By taking the logarithm of L and using the optimization toolbox in MATLAB, 385 we obtain a matrix containing the transmission rates of the Delta and non-Delta 386 variants between age groups. 28 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Impact of the delta vari